Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 1
2009 3
2010 1
2011 3
2012 1
2013 1
2014 2
2016 1
2017 2
2018 1
2019 1
2020 5
2021 4
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, Hoch M, Cortes JE, Hughes TP; ASC4FIRST Investigators. Hochhaus A, et al. N Engl J Med. 2024 Sep 12;391(10):885-898. doi: 10.1056/NEJMoa2400858. Epub 2024 May 31. N Engl J Med. 2024. PMID: 38820078 Clinical Trial.
Clinical and immunological features in ACKR1/DARC-associated neutropenia.
Palmblad J, Sohlberg E, Nilsson CC, Lindqvist H, Deneberg S, Ratcliffe P, Meinke S, Mörtberg A, Klimkowska M, Höglund P. Palmblad J, et al. Among authors: deneberg s. Blood Adv. 2024 Feb 13;8(3):571-580. doi: 10.1182/bloodadvances.2023010400. Blood Adv. 2024. PMID: 38039514 Free PMC article.
Omalizumab alleviates pruritus in myeloproliferative neoplasms.
Ravn Landtblom A, Ungerstedt J, Hedlund A, Tobiasson M, Deneberg S, Jädersten M. Ravn Landtblom A, et al. Among authors: deneberg s. Haematologica. 2023 Jul 1;108(7):1968-1971. doi: 10.3324/haematol.2022.281639. Haematologica. 2023. PMID: 36700402 Free PMC article. No abstract available.
Epigenetics in myeloid malignancies.
Deneberg S. Deneberg S. Methods Mol Biol. 2012;863:119-37. doi: 10.1007/978-1-61779-612-8_7. Methods Mol Biol. 2012. PMID: 22359290 Review.
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option.
Dolinska M, Cai H, Månsson A, Shen J, Xiao P, Bouderlique T, Li X, Leonard E, Chang M, Gao Y, Medina JP, Kondo M, Sandhow L, Johansson AS, Deneberg S, Söderlund S, Jädersten M, Ungerstedt J, Tobiasson M, Östman A, Mustjoki S, Stenke L, Le Blanc K, Hellström-Lindberg E, Lehmann S, Ekblom M, Olsson-Strömberg U, Sigvardsson M, Qian H. Dolinska M, et al. Among authors: deneberg s. Blood. 2023 Jul 6;142(1):73-89. doi: 10.1182/blood.2022016896. Blood. 2023. PMID: 37018663 Free PMC article.
Acute myeloid leukemia in very old patients.
Lazarevic VL, Bredberg A, Lorenz F, Öhlander E, Antunovic P, Cammenga J, Wennström L, Möllgård L, Deneberg S, Derolf Å, Höglund M, Juliusson G; Swedish AML Registry. Lazarevic VL, et al. Among authors: deneberg s. Haematologica. 2018 Dec;103(12):e578-e580. doi: 10.3324/haematol.2018.196691. Epub 2018 Jun 28. Haematologica. 2018. PMID: 29954935 Free PMC article. No abstract available.
Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications.
Nilsson C, Linde F, Hulegårdh E, Garelius H, Lazarevic V, Antunovic P, Cammenga J, Deneberg S, Eriksson A, Jädersten M, Björkvall CK, Möllgård L, Wennström L, Ölander E, Höglund M, Juliusson G, Lehmann S. Nilsson C, et al. Among authors: deneberg s. Haematologica. 2023 Apr 1;108(4):1015-1025. doi: 10.3324/haematol.2022.281233. Haematologica. 2023. PMID: 36005563 Free PMC article.
A risk score based on real-world data to predict early death in acute promyelocytic leukemia.
Österroos A, Maia T, Eriksson A, Jädersten M, Lazarevic V, Wennström L, Antunovic P, Cammenga J, Deneberg S, Lorenz F, Möllgård L, Uggla B, Ölander E, Aguiar E, Trigo F, Höglund M, Juliusson G, Lehmann S. Österroos A, et al. Among authors: deneberg s. Haematologica. 2022 Jul 1;107(7):1528-1537. doi: 10.3324/haematol.2021.280093. Haematologica. 2022. PMID: 35081688 Free PMC article.
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial.
Jädersten M, Lilienthal I, Tsesmetzis N, Lourda M, Bengtzén S, Bohlin A, Arnroth C, Erkers T, Seashore-Ludlow B, Giraud G, Barkhordar GS, Tao S, Fogelstrand L, Saft L, Östling P, Schinazi RF, Kim B, Schaller T, Juliusson G, Deneberg S, Lehmann S, Rassidakis GZ, Höglund M, Henter JI, Herold N. Jädersten M, et al. Among authors: deneberg s. J Intern Med. 2022 Dec;292(6):925-940. doi: 10.1111/joim.13553. Epub 2022 Aug 18. J Intern Med. 2022. PMID: 35934913 Free PMC article. Clinical Trial.
Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study.
Rosso A, Juliusson G, Lorenz F, Lehmann S, Derolf Å, Deneberg S, Jädersten M, Antunovic P, Cammenga J, Möllgård L, Wennström L, Ölander E, Ehinger M, Fogelstrand L, Höglund M, Lazarevic VL. Rosso A, et al. Among authors: deneberg s. Leuk Lymphoma. 2021 Aug;62(8):1973-1981. doi: 10.1080/10428194.2021.1889539. Epub 2021 Mar 10. Leuk Lymphoma. 2021. PMID: 33719843 Free article.
34 results